This Pharma Magazine is the source for a plethora of unique Pharma articles. Several notable figures from top pharma organisations are featured in the R&D, Manufacturing and Clinical Trials sections, with their expert knowledge of the field.
Vaccines and antivirals have been the fundamental pillars in the battle against infectious diseases
In the first article in this series The Glocalisation Challenge I differentiated between astute and nave glocalisers and in this fourth and final article
Approximately million people worldwide are living with a rare disease and about half of those affected by rare diseases are children
Cell culture media is a significant driver of productivity within biopharmaceutical manufacturing processes
Rapid scientific and technological innovations have enabled us to manipulate complex living systems and expanded our understanding of human biology
Although less well known than other drug development phases human factors engineering HFE is critical to meeting regulatory expectations for drugdevice combination products
Nowadays nanoparticles are a popular toolbox used in cancer research for improving the pharmaceutical capacity of therapeutic agents
Although slowly fading away from the collective memory the SARSCoV pandemic that started in early and the unprecedented health crisis on a global scale that followed reminded us about the necessity of pandemic preparedness
The dichotomous branching of the lungs from the th generation the trachea to the rd generation of the lungs offers a surface area of m of the alveolar region
Drug development has transformed immeasurably over the past decade Even before the Covid pandemic and the conflict in Ukraine
A tremendous amount of documentation is created throughout the clinical trial lifecycle
International and Regional BioPharma meets online inperson at Suntec Singapore this month
Nitrosamine describes a class of compounds with a nitroso groups chemical structure bonded to an amine
